Mia Talmor, M.D., FACS

Dr. Kaner is Associate Attending Physician at the NewYork-Presbyterian Weill Cornell Medical Center and Associate Professor of Clinical Medicine and Genetic Medicine at Weill Cornell Medicine. Dr. Kaner was the Principal Investigator of the Weill-Cornell Medicine site of the NIH-sponsored Idiopathic Pulmonary Fibrosis (IPF) Clinical Research Network for which he chaired the Adjudication Committee. He has extensive experience in the phenotyping of subjects with lung disease and their enrollment in research studies. He leads a monthly multidisciplinary ILD conference with Dr. William Travis (MSKCC) and Dr. Chen Zhang (WCM) for the past 15 years. He is the director of the New York Presbyterian Hospital – Weill Cornell Medicine Pulmonary Fibrosis Foundation Clinical Center of Excellence. He participates in clinical trials evaluating various pharmacologic interventions in IPF and other ILDs, sponsored by both NIH and pharma. He leads an ILD biobank, which enhances future translational research opportunities. He leads an observational study to determine the incidence and natural history of ILD following COVID-19 acute respiratory failure.Dr. Kaner chairs the bronchoscopy sub-study committee of the NHLBI SPIROMICS and SOURCE research networks, which uses RNA-sequencing to evaluate gene expression changes in lung cells associated with smoking and COPD endotypes. He is analyzing the effects of doxycycline on BAL matrix metalloproteinase (MMP) inhibition in HIV-positive individuals with early emphysema, based on his previous translational work. He is also participating in pharmacologic intervention studies in COPD and emphysema sponsored by the ALA, DOD and NIH, including leadership (with Dr. Marshall Glesby) of a Phase II multicenter trial of doxycycline to slow emphysema progression in PLWH. He is the Associate Director of the T32 training program and Associate Fellowship Program Director.

Dr. Marchalik graduated Magna Cum Laude and Phi Beta Kappa from Barnard College, Columbia University. She obtained her medical degree from Georgetown University School of Medicine, where she was inducted into the Alpha Omega Alpha Honor Society. During her time in medical school, she was accepted into a highly prestigious one-year fellowship at the National Institutes of Health as a part of the Medical Research Scholars Program. She completed her Dermatology residency and fellowship in Dermatopathology at Johns Hopkins University. Dr. Marchalik is dermatopathology trained and interests include general dermatology with a focus on alopecia (hair loss).